Muscle Spasm Market - Forecast(2024 - 2030)

Report Code: HCR 0296 Report Format: PDF + Excel

Muscle Spasm Market Overview

Muscle Spasm Market Size is estimated to reach $8.3 billion by 2030, growing with a CAGR of 8.4% during the forecast period 2023-2030. A muscle spasm is a spontaneous, unforeseen narrowing of a muscle or assembling of muscles of the body. A muscle spasm is generally called a muscle cramp or involuntary hypertonicity. Muscle spasm typically occurs after a very strong injury and is an unforeseen effect of intense pain in the area injured, which ends after five to ten minutes. Muscle spasm, in regular circumstances, really harms the body. The most commonly affected muscles are the lower leg muscles, the front of the thigh and the back of the thigh. Besides, muscles of the arms, feet, hands and waist are moreover affected, despite the fact that the degree is low. According to NCBI, the majority (60% to 85%) of the population has had (nonspecific) back pain of muscular origin at some time or other. The rising instances of muscle compression particularly among the geriatric populace are projected to expand the development of the deals for the Muscle Spasm Market during the forecast period 2023-2030.

Muscle Spasm Market Report Coverage

The report: “Muscle Spasm Market Forecast (2023-2030)" by IndustryARC, covers an in-depth analysis of the following segments in the Muscle Spasm Market.

By Drug Type: Baclofen, Botulinum Toxin, Diazepam, Tizanidine and Others.
By Route of Administration: Oral, Intramuscular and Others.
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy and Online Pharmacy.
By Geography: North America (the U.S., Canada and Mexico), Europe (Germany, the UK, France, Italy, Spain, Russia and the Rest of Europe), Asia-Pacific (China, Japan India, South Korea, Australia and New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and the Rest of South America) and the Rest of the World (the Middle East and Africa).

Key Takeaways

  • Geographically, North America held a dominant market share in 2022. It is due to a robust medical infrastructure supported by excellent insurance coverage across the geographies and a higher tendency of the population to seek medical attention in cases such as muscle spasms. Moreover, North America is expected to offer lucrative growth opportunities over the forecast period of 2023-2030. It is due to a growing geriatric population with an extensive need for urgent medical care.
  • A growing geriatric population supported by the rising number of hospitals entering the segment of the Muscle Spasm Market are some of the recognized drivers of the market.
  • A detailed analysis of the strengths, weaknesses, opportunities and threats would be provided in the Muscle Spasm Market Report.

Muscle Spasm Market - Market Share (%) by region, 2022

Muscle Spasm Market

For More Details on This Report - Request for Sample

Muscle Spasm Market Segment Analysis- by Drug Type

The Muscle Spasm Market based on drug type can be further segmented into Baclofen, Botulinum Toxin, Diazepam, Tizanidine and Others. The Baclofen segment held a dominant market share in 2022. Baclofen is utilized to treat torment and specific sorts of spasticity (muscle firmness and snugness) from numerous cases of sclerosis, spinal string wounds or other spinal line sicknesses. Baclofen is in a class of prescriptions called skeletal muscle relaxants. Baclofen acts up on the spinal line nerves and diminishes the number and seriousness of muscle fits brought about by various sclerosis or spinal rope conditions. It eases torment and further develops muscle development. However, Botulinum toxin is estimated to be the fastest-growing segment, with a CAGR of 9.3% over the forecast period of 2023-2030. It is due to the rising use of botulinum toxins in children since it eases the pain faster.

Muscle Spasm Market Segment Analysis - by Route of Administration

The Muscle Spasm Market based on the route of administration can be further segmented into oral, intramuscular and Others. The segment of oral route of administration dominated the market in 2022. Recently, the utilization of oral muscle relaxants has made progress and more proof is accessible to assess their adequacy. Moreover, oral drug delivery is one of the easiest, most convenient and most acceptable methods of drug intake among consumers. However, the intramuscular segment is estimated to be the fastest-growing segment, with a CAGR of 9.7% over the forecast period of 2023-2030.

Muscle Spasm Market Segment Analysis - by Geography

The Muscle Spasm Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and the Rest of the World. North America held a dominant market share of 38% in 2022 and is estimated to be the fastest-growing region over the forecast period of 2023-2030. The worldwide Muscle Spasm Market is categorized into the regions of North America, Latin America, Asia-Pacific, Europe and the Middle East & Africa. These regions are additionally divided into countries. Among these, North America arose predominantly because of the presence of major companies operating in the muscle spasm industry. This, combined with high rates of muscle spasm in the developed countries of Canada and the US would add fuel to the regional growth of this market. Asia-Pacific is projected to emerge as the quickest developing business sector for muscle spasms. This is attributed to the ascent in the geriatric populace and the growing tendency towards sports and proactive tasks that has the chance of gentle injury cases, particularly among athletes.

Muscle Spasm Market Drivers

Rising Sports and Outdoor Activities:

The rising number of sports and outside exercises consequently creates the chance of sports wounds like muscle spasms, sprains and others. The rising instances of activity-related wounds would boost the general development of this market. Moreover, expanding interests in innovative work and the rising mindfulness about muscle fit and their potential drugs would, similarly, help with the development of the general Muscle Spasm Market in the forecast period. According to research conducted by NCBI, almost 61% of people are involved in sports activities at least once a week.

Advancement in Healthcare Infrastructure:

According to the latest research reports, almost 440 deals were sealed with an investment of around $14 billion across many digital health companies in the U.S. Emerging technologies are reshaping medical care in many ways how buyers access it, which suppliers convey and what health outcomes it accomplishes. Emerging technologies such as connected and cognitive gadgets, electroceuticals, mechanical technology, 3D printing, blockchain and automated process robotization are accelerating market growth. A portion of these developments are well defined for medical care; others are further developed in nonhealthcare areas, yet hold enormous potential in medical care.

Muscle Spasm Market Challenge

Lack of Awareness in Emerging Countries:

A lack of disease awareness and education of both medical services experts and patients themselves is impacting the industry. In most cases analyzed, most patients are past the mark of treatment. Low awareness of the right treatment conventions or the advantages of new prescriptions can additionally fuel this issue.

Key Market Players

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Muscle Spasm Industry. The top 10 companies in the Muscle Spasm Market are-

  1. Elite Pharmaceuticals Inc
  2. F. Hoffmann-La Roche Ltd
  3. Novartis AG
  4. Ipsen Pharma
  5. Acorda Therapeutics
  6. Merz Pharma
  7. Sun Pharmaceutical Industries Ltd.
  8. Beximco Pharmaceuticals Ltd.
  9. Zydus Cadila
  10. Johnson & Johnson Private Limited

Recent Developments

  • In June 2022, Amneal Pharmaceuticals, Inc announced the commercial launch of LYVISPAH, a baclofen oral granule (5,10 and 20mg) approved by the U.S. Food and Drug Administration.
  • In November 2021, Neurana Pharmaceuticals has closed subject enrolment in a Stage III RESUME-1 clinical preliminary of its treatment, Tolperisone, to treat muscle spasms connected to intense, painful outer muscle conditions.
  • In July 2021, FDA approved extended BOTOX® (onabotulinumtoxinA) mark to incorporate eight new muscles to treat grown-ups with upper Appendage spasms.

Relevant Titles

Oral Care Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis

Report Code: HCR 1555940057598

Cryotherapy and Cryosurgery Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis

Report Code: HCR 0013

Acute Care Ventilator Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis

Report Code: HCR 54937

For more Lifesciences and Healthcare Market reports, please click here

1. Muscle Spasm Market - Overview
    1.1 Definitions and Scope
2. Muscle Spasm Market - Executive Summary
3. Muscle Spasm Market - Comparative Analysis
    3.1 Company Benchmarking - Key Companies
    3.2 Global Financial Analysis - Key Companies
    3.3 Market Share Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Muscle Spasm Market - Start-up Companies Scenario (Premium)
    4.1 Key Start-up Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Muscle Spasm Market – Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Muscle Spasm Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porter's Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Muscle Spasm Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Muscle Spasm Market – by Drug Type
    8.1 Baclofen
    8.2 Botulinum Toxin
    8.3 Diazepam
    8.4 Tizanidine
    8.5 Others
9. Muscle Spasm Market – by Route of Administration
    9.1 Oral
    9.2 Intramuscular
    9.3 Others
10. Muscle Spasm Market – by Distribution Channel
    10.1 Hospital Pharmacies
    10.2 Retail Pharmacies
    10.3 Online Pharmacies
11. Muscle Spasm Market - by Geography
    11.1 North America
        11.1.1 The U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 The UK
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 The Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 The Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 The Rest of South America
    11.5 The Rest of the World
        11.5.1 The Middle East
        11.5.2 Africa
12. Muscle Spasm Market - Entropy
13. Muscle Spasm Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Market Share by Region – Key companies
        13.1.2 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Muscle Spasm Market – Key Company List by Country Premium Premium
15. Muscle Spasm Market - Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
* "Financials would be provided to private companies on best-efforts basis."
Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.
List of Table s:

Table 1: Muscle Spasm Market Overview 2021-2026
Table 2: Muscle Spasm Market Leader Analysis 2018-2019 (US$)
Table 3: Muscle Spasm Market Product Analysis 2018-2019 (US$)
Table 4: Muscle Spasm Market End User Analysis 2018-2019 (US$)
Table 5: Muscle Spasm Market Patent Analysis 2013-2018* (US$)
Table 6: Muscle Spasm Market Financial Analysis 2018-2019 (US$)
Table 7: Muscle Spasm Market Driver Analysis 2018-2019 (US$)
Table 8: Muscle Spasm Market Challenges Analysis 2018-2019 (US$)
Table 9: Muscle Spasm Market Constraint Analysis 2018-2019 (US$)
Table 10: Muscle Spasm Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Muscle Spasm Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Muscle Spasm Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Muscle Spasm Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Muscle Spasm Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Muscle Spasm Market Value Chain Analysis 2018-2019 (US$)
Table 16: Muscle Spasm Market Pricing Analysis 2021-2026 (US$)
Table 17: Muscle Spasm Market Opportunities Analysis 2021-2026 (US$)
Table 18: Muscle Spasm Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Muscle Spasm Market Supplier Analysis 2018-2019 (US$)
Table 20: Muscle Spasm Market Distributor Analysis 2018-2019 (US$)
Table 21: Muscle Spasm Market Trend Analysis 2018-2019 (US$)
Table 22: Muscle Spasm Market Size 2018 (US$)
Table 23: Muscle Spasm Market Forecast Analysis 2021-2026 (US$)
Table 24: Muscle Spasm Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Muscle Spasm Market, Revenue & Volume, By Causes, 2021-2026 ($)
Table 26: Muscle Spasm Market By Causes, Revenue & Volume, By Muscular injury, 2021-2026 ($)
Table 27: Muscle Spasm Market By Causes, Revenue & Volume, By Spinal nerve compression, 2021-2026 ($)
Table 28: Muscle Spasm Market By Causes, Revenue & Volume, By Sprains and strains of the muscle diabetic ketoacidosis, 2021-2026 ($)
Table 29: Muscle Spasm Market, Revenue & Volume, By Drug, 2021-2026 ($)
Table 30: Muscle Spasm Market By Drug, Revenue & Volume, By Diazepam, 2021-2026 ($)
Table 31: Muscle Spasm Market By Drug, Revenue & Volume, By Quinine, 2021-2026 ($)
Table 32: Muscle Spasm Market By Drug, Revenue & Volume, By Phonation, 2021-2026 ($)
Table 33: Muscle Spasm Market By Drug, Revenue & Volume, By Carbamazepine, 2021-2026 ($)
Table 34: North America Muscle Spasm Market, Revenue & Volume, By Causes, 2021-2026 ($)
Table 35: North America Muscle Spasm Market, Revenue & Volume, By Drug, 2021-2026 ($)
Table 36: South america Muscle Spasm Market, Revenue & Volume, By Causes, 2021-2026 ($)
Table 37: South america Muscle Spasm Market, Revenue & Volume, By Drug, 2021-2026 ($)
Table 38: Europe Muscle Spasm Market, Revenue & Volume, By Causes, 2021-2026 ($)
Table 39: Europe Muscle Spasm Market, Revenue & Volume, By Drug, 2021-2026 ($)
Table 40: APAC Muscle Spasm Market, Revenue & Volume, By Causes, 2021-2026 ($)
Table 41: APAC Muscle Spasm Market, Revenue & Volume, By Drug, 2021-2026 ($)
Table 42: Middle East & Africa Muscle Spasm Market, Revenue & Volume, By Causes, 2021-2026 ($)
Table 43: Middle East & Africa Muscle Spasm Market, Revenue & Volume, By Drug, 2021-2026 ($)
Table 44: Russia Muscle Spasm Market, Revenue & Volume, By Causes, 2021-2026 ($)
Table 45: Russia Muscle Spasm Market, Revenue & Volume, By Drug, 2021-2026 ($)
Table 46: Israel Muscle Spasm Market, Revenue & Volume, By Causes, 2021-2026 ($)
Table 47: Israel Muscle Spasm Market, Revenue & Volume, By Drug, 2021-2026 ($)
Table 48: Top Companies 2018 (US$) Muscle Spasm Market, Revenue & Volume
Table 49: Product Launch 2018-2019 Muscle Spasm Market, Revenue & Volume
Table 50: Mergers & Acquistions 2018-2019 Muscle Spasm Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Muscle Spasm Market 2021-2026
Figure 2: Market Share Analysis for Muscle Spasm Market 2018 (US$)
Figure 3: Product Comparison in Muscle Spasm Market 2018-2019 (US$)
Figure 4: End User Profile for Muscle Spasm Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Muscle Spasm Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Muscle Spasm Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Muscle Spasm Market 2018-2019
Figure 8: Ecosystem Analysis in Muscle Spasm Market 2018
Figure 9: Average Selling Price in Muscle Spasm Market 2021-2026
Figure 10: Top Opportunites in Muscle Spasm Market 2018-2019
Figure 11: Market Life Cycle Analysis in Muscle Spasm Market
Figure 12: GlobalBy Causes Muscle Spasm Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy Drug Muscle Spasm Market Revenue, 2021-2026 ($)
Figure 14: Global Muscle Spasm Market - By Geography
Figure 15: Global Muscle Spasm Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global Muscle Spasm Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 18: US Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 60: U.K Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 93: China Muscle Spasm Market Value & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($) Muscle Spasm Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Muscle Spasm Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122: Russia Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Muscle Spasm Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%) Muscle Spasm Market
Figure 131: Developments, 2018-2019* Muscle Spasm Market
Figure 132: Company 1 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Muscle Spasm Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Muscle Spasm Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Muscle Spasm Market Net Sales Share, By Geography, 2018 (%)